Back to search results
NCT06822530

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Recruiting
NAAges 45–75InterventionalScreening
Fred Hutchinson Cancer Center
~682 participants
Updated 2026-06-22 on ClinicalTrials.gov
What's tested:Best PracticeEducational InterventionElectronic Health Record ReviewInterviewSupportive CareSurvey Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of colonoscopy completion within 6 months
Measured over At 6 months after randomization
+1 more outcome measured

Conditions

Colorectal Carcinoma

Explore related trials

Colorectal Carcinoma

Where it's being run

1 sites across 1 states
Washington1

Study leadership

  • Rachel B. Issaka, MD, MAS · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium

Who to contact

Rachel B. Issaka, MD, MAS
[email protected]
206-667-1447
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

PATIENTS: Age \>= 45 years old and =\< 75 years old
PATIENTS: Receives care at an Harborview Medical Center (HMC) or University of Washington-Kent-Des Moines (UW-KDM) or University of Washington- Federal Way (UW-Federal Way) primary care clinic
PATIENTS: \>= 1 month from documented abnormal FIT result
PATIENTS: Has not received a colonoscopy between the abnormal FIT and enrollment
CLINIC STAFF: HMC, UW-Federal Way, or UW-KDM physician or staff member who provides primary care or gastroenterology care
CLINIC STAFF: Staff in the Fred Hutchinson (Fred Hutch)/UW Medicine Population Health Program that provide colorectal cancer screening and navigation

What this trial measures

  • Rate of colonoscopy completion within 6 monthsAt 6 months after randomization

    Will descriptively compare the rates of colonoscopy completion at 6 months. Will fit a generalized mixed effects model with a logit link and a random effect for clinic. Will include an indicator variable for the randomized group (usual care versus (vs.) multilevel intervention) and adjust for patient-level clinical and demographic factors (e.g., age, sex, race, ethnicity, primary language, marital status, last primary care visit, insurance) and clinic-level factors (e.g., clinic size, average full-time equivalent providers per clinic, average provider panel size, primary care provider mix (Doctor of Medicine/Doctor of Osteopathic Medicine vs. other advanced degree).

  • Time to colonoscopy completionBeginning 6 months after randomization until study completion

    Will assess the time to colonoscopy completion in days and compare these times across individual clinics.